Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by QContinuum1on Apr 29, 2024 11:24am
129 Views
Post# 36012683

RE:RE:RE:FDA approval

RE:RE:RE:FDA approval
Starkicker wrote: I'm going to be watching the Q1 numbers and report closely in a couple of weeks. If there isn't a significant uptick in revenue I'll reasses my interest in this company. When management says things like they did back in November then nothing happens, I have to question their authenticity and my investment.


Agreed.  I would also argue that we were also told many a thing at the YE call which now they need to make good on.

I get the mgmt double talk and all of that, but they have made commitments and statements leading up to this (and realistically the next couple) call(s) and they need now execute.

The time for words and blather is over, they have all the need to make the SP organically increase, and not by a little bit.
<< Previous
Bullboard Posts
Next >>